FDA Drug Application (012380) for ZARONTIN by PARKE DAVIS

Back to FDA Applications sponsored by PARKE DAVIS

Application Number012380
Product Number001
FormCAPSULE;ORAL
Dosage250MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameZARONTIN
Active IngredientETHOSUXIMIDE

Active IngredientCount
List of drugs with Active Ingredient ETHOSUXIMIDE2


Back to FDA Applications sponsored by PARKE DAVIS